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After delivering a student lecture on the quantitative attributes of human infertility, the very poor
quality of human sperm in comparison to other species, and the biologically unlikely long “time-to-
pregnancy” statistics even among young people, I generally pose to my audience of several hundred
young and healthy students the following question. “All of these characteristics would be enough
to make most wild species go extinct; look around you; is that what is happening to us? If not,
why not?” Fairly quickly, they begin to talk about medical information and research, IVF (in vitro
fertilization), etc. This situation hides, however, an important paradox for those who work in or
fund research in reproduction. Namely, it is one thing to look at the level of the population, and
quite another to look at the individual. Many not directly involved tend to see the former level, with
overpopulation an issue, and contraception mostly a socio-economic matter, and anyway infertility
is not life-threatening, like cancer. For the affected individual or couple, it looks very different.
Moreover, we are confronted with severe and unresolved issues in regard to livestock reproduction,
as well as for endangered wildlife.
In the following, selected research challenges in reproduction are listed. This is not exhaustive
and less about their clinical importance, but more about the extent of our knowledge deficit
and the potential translational impact such basic research could have. It will be noticeable that
in many of these areas a paradigm shift in our thinking may be required. So much of current
thinking about research in reproduction still relies on simplistic concepts that are at least 50
years old. The reproductive system is different from most other physiological systems in the body
in that its functionality in the adult depends on a highly dynamic but very tightly controlled
proliferation and differentiation of specialized cell types. And while deficits in functionality may
not necessarily be life-threatening, its close informational interdependence with other physiological
systems nevertheless gives it great importance in our understanding of health and disease.
NEOHORMONES AND EVOLUTION
The vast majority of interventions for fertility treatment or contraception refer to only a small
number of hormones involved with the hypothalamo-pituitary-gonadal (HPG) axis, namely
gonadotropins, GnRH (gonadotropin releasing hormone), and the sex steroids, all of which were
identified many decades ago. Whilst these are without doubt central to the control of reproduction
in both males and females, since then many hundreds of new regulatory molecules have been
identified, but few if any have been applied in a clinical context to regulate reproduction. Of
these novel molecules, the neohormones are of particular interest. These are defined as hormone-
receptor systems which evolved concurrently with the emergence of mammals from their reptilian
ancestors to address the specifically mammalian defining traits of viviparity, internal fertilization,
maternal adaptation to pregnancy, lactation, and reproductive behavior (Anand-Ivell et al., 2013).
Ivell Research in Reproduction: Challenges, Needs, and Opportunities
Besides human chorionic gonadotropin (hCG) in humans,
interferon-tau in ruminants, and oxytocin, the relaxin family
of insulin-like peptides have received most attention. However,
except for hCG and oxytocin, none of these have entered
significantly into the treatment of reproductive conditions in any
species, even though relaxin itself has been shown to be very
effective in reducing pregnancy loss inmonkeys (Goldsmith et al.,
2004; Einspanier et al., 2009). One part of the problem is that
gaining regulatory approval for novel agents in the context of
reproduction and potential pregnancy is very difficult; another
is the simple cost of developing appropriate compounds whose
synthesis is currently very expensive, though some new non-
peptide mimetics appear to be on the horizon (Agoulnik et al.,
2016). The result is that currently the majority of pharmaceutical
interventions in reproduction are based on science which is at
least 50 years old. This situation needs to change.
SYSTEMS APPROACHES VS. THE MAGIC
BULLET—THE MYTH OF THE GOLDEN
BIOMARKER
Historically, research in reproduction, as in most areas of
physiology, has been dominated by the notion that there can be
a single biomarker reflecting a particular health status, and as a
corollary a single molecular target which can pharmaceutically
resolve a health issue. For many aspects of reproduction, from
oocyte and blastocyst status, to implantation and early pregnancy
loss, this goal is still a long way off, with many modern global
approaches in transcriptomics, epigenomics, and proteomics
failing to identify an unambiguous and reproducible signature
for a particular condition. Part of the issue may be in our
rudimentary bioinformatic ability to identify an appropriate
“fingerprint” amongst the huge amount of data now available.
But part may also be in our still rather static paradigm of what
is health and what is disease (see below).
ENDOCRINE “NOISE” AND IMPLANTATION
We now recognize that in any dialogue between component
cells and tissues a multiplex of diverse factors (hormones,
metabolites), their receptors, and signaling pathways are
involved, to form a dynamic and complex network of
interactions. In differentiation, in health and disease, there are
subtle shifts in the coordinates of such a network, which may
or may not be reflected in individual parameters. This is why,
for example, there are so many instances of gene deletions in
mice (a very gross intervention) with no obvious phenotypic
effect, or with an impact only under stress conditions, or with
other concomitant deletions. Hence when we use the term
“redundancy” for a particular gene product, this does not imply
that it is without function, but merely that we do not yet
understand its physiological context. Evolution has honed the
genomes of all extant species to represent the perfect compromise
for that organism in its ecological context.
What is becoming clear, and what we still cannot really grasp
in a scientific sense, is the dynamic nature of any particular
informational network. This leads to the notion of “noise”
in a system. For example, in the developing oocyte or early
embryo, health may be associated with a “quiet” system, with low
statistical variance of its component interactions (Leese, 2012).
At implantation, there is a dialogue between the implanting
blastocyst and the endometrium, involving multiple signaling
pathways. In a healthy situation such informational exchange will
be minimal, but in an unhealthy situation the dialogue between
embryo and endometrium will intensify; there will be an increase
in endocrine “noise.” This may resolve itself and implantation
succeeds, or it may worsen and lead to rejection (Macklon and
Brosens, 2014). The key point to note here is that measurement
of a single element in that conversational network may only show
an increase in variance, i.e., noise, without any impact on average
parameter values.
To extend this concept further, it has been shown that the
impact of some endocrine disrupting chemicals (EDCs) may be
to induce a significant increase in parameter variance without
affecting the parameter mean. Such results are also linked to the
concept of responders vs. non-responders, which can statistically
mask real physiological effects (Bellingham et al., 2012).
Thus, one of the major challenges facing research in
reproductive physiology will be to develop and quantify ways
of assessing the dynamics of intercellular networks, such as to
measure “noise” and treat this as a parameter in its own right,
with variance being given as much importance as the mean.
UTERINE PERISTALSIS AND DISEASE
As an organ, the uterus is a highly dynamic structure with its
functional endometrium enclosed within a regulated muscular
envelope, the myometrium. It is thus much like the gut, though
surprisingly we know far less about the dynamic control of
the uterus than we do about the digestive tract. At a gross
level, in healthy individuals the uterus shows cyclic peristaltic
waves oriented downwards and outwards at menses with the
isthmus, connecting the uterus to the oviduct, closed to ensure
the correct expulsion of menstrual fluid. At mid-cycle ovulation,
when the organism is sexually most receptive, the directionality
of peristalsis is reversed, with contractility at ejaculation aimed
at conveying a bolus of ejaculated semen to the upper end of
the uterus and, depending upon the side of the ovulating ovary,
with the ipsilateral opening of the isthmus to allow sperm to
reach the site of fertilization in the ipsilateral oviduct (Kunz
and Leyendecker, 2002). During implantation and pregnancy
the myometrium becomes more or less quiescent, following a
period of regulated mild contraction to assist implantation and
embryo spacing (particularly in polytocous species). This changes
dramatically at term, when oxytocin-induced contractility leads
to the expulsion of the fetus and placenta and subsequent
involution of the uterus.
This is the ideal scenario for most mammals, though in
humans it appears that there may be severe disruption of
one or other aspect. For example, it is now considered that
endometriosis may have its origin in a retrograde peristalsis at
menses, whereby menstrual material with resident stem cells is
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transported antero-dorsally through an open isthmus to enter
the peritoneal cavity. This can occur in women at any time
after puberty. Secondly, it has been shown for women attending
an infertility clinic, but otherwise with positive reproductive
parameters, that the direction of uterine peristalsis, instead of
being toward an open ipsilateral isthmus at mid-cycle, is rather
in the opposing direction, or that the ipsilateral isthmus is closed
(Kunz and Leyendecker, 2002). Routine reproductive diagnosis
generally does not assess uterine dynamics, largely one suspects
because there is very little therapeutically that can be done. The
research in this area is very sporadic and several decades old, in
spite of the obvious translational implications. We still have no
idea about the causes of uterine peristaltic directionality, or the
way in which cycle-dependent hormones may modify this. Early
attempts to assess the influence of steroids and oxytocin were
without significant result (Kunz et al., 1998). In the gut, such
directionality is co-regulated by resident Cajal-like cells; there
is still little information at all about the presence or function of
similar cells (also called telocytes) in the uterus of any species
(Hutchings et al., 2009; Dodds et al., 2015). There is a very
obvious need here for intensive research into the basic biology
of the system and about appropriate methods of early diagnosis
and treatment.
INACCESSIBILITY OF THE
MID-GESTATION FETUS AND DOHaD
A major issue in understanding early fetal development and
the progression of pregnancy is that the key period of
fetal organogenesis, as well as of placental establishment and
growth is also a period when the uterine contents are least
accessible to analysis. Other than high resolution ultrasound
and associated Doppler blood-flow measurements, the growing
fetus and placenta are effectively invisible to the researcher.
Some progress has been made by looking at fetal cells isolated
from the maternal bloodstream, particularly as a source of
fetal DNA. One very useful instrument had been the analysis
of amniotic fluid collected at routine amniocentesis, i.e.,
approximately between weeks 12 and 20 of human pregnancy
(Jensen et al., 2015). However, the risks involved for mother
and child, and the development of alternative sources of fetal
DNA (see above), have led to a significant reduction in such
analyses, and anyway amniocentesis was always restricted to
a limited number of indicated cases only. There is a definite
need for other novel surrogates of fetal and placental well-
being, particularly during the important transition from first
to second trimester, when the risk of miscarriage is also
high.
Another reason why this is so important is that this is a
time when maternal and exogenous impacts on placental and
fetal development are likely to have a considerable long-term
effect on the health of the offspring. The Developmental Origins
of Health and Disease (DOHaD) hypothesis, which is well-
founded using animal models, as well as through epidemiological
studies (Hanson and Gluckman, 2014), makes it clear that
subtle influences (such as maternal obesity or diabetes) on fetal
organogenesis and physiology can have life-long consequences.
Monitoring of such early effects (preferably using biochemical
surrogates) could go a long way toward developing appropriate
timely interventional strategies and defining the molecular basis
of such impacts.
SPERM AS NON-SOMATIC CELLS
The male gamete is a highly unusual cell. It is the only cell
type to have its principal function outside of the body; it is also
largely unable to transcribe or repair its DNA. In its mature
form it has extremely little cytoplasm, effectively prohibiting
diffusion kinetics from playing a major role in cell signaling and
physiology. Instead the plasmamembrane and other intracellular
membrane structures host most of the functional dynamism
required for the cell to fulfill its function, with the plasma
membrane exhibiting a marked and changing spatial variability
during the transit of the sperm from epididymal storage to
oocyte fertilization. It is also enclosed by a dense and highly
variable glycocalyx, which at ca. 200µm certainly impacts on
any inter-cellular/inter-molecular interactions. We now know
that once sperm are released from quiescence during storage in
the cauda epididymis and following the temperature and pH
shock at ejaculation upon being released from scrotal coolness
(32
◦
C) to the relative warmth (37
◦
C) of the female tract, they
are already embarked on an apoptotic pathway (Koppers et al.,
2011). Only those gametes which proceed to the oviduct and
fertilize an oocyte can escape this fate. All the remainder undergo
apoptotic cell death and are phagocytosed. This image of the
spermatozoon is thus very different from that of any conventional
somatic cell, and yet we still apply many of the paradigms
derived from researching effectively immortal somatic cells when
we try to understand sperm function. Future research must
work within a more holistic sperm-centric environment if we
are to understand better the physiology and pathology of the
spermatozoon.
GONADAL PROGRAMMING OF PUBERTY
AND OLD AGE
Age-related debility and disease is one of the greatest socio-
economic burdens on global society, yet we still know relatively
little about its biological etiology and consequently have little
to offer in terms of prevention. The function of the ovaries
and testes in this context is not well-understood. For women,
the loss of oocyte recruitment at the menopause and resulting
rapid decline in follicle-derived sex hormones is well-established
and the basis for a steroid-based hormone-replacement therapy
(HRT). But the sex steroids are not the only ovarian products
to decline with age. The follicle-derived insulin-like peptide
3 (INSL3), which is essential to promote steroid production
during reproductive life (Glister et al., 2013), also declines, as
also anti-mullerian hormone and inhibin. For INSL3, there is
evidence to suggest that this may have a direct impact on bone
cells to promote bone formation and limit osteoporosis (Ferlin
et al., 2013). Even for the sex steroids we still have only a
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poor understanding of the possible roles of their metabolites.
Thus, there is still much room for a more comprehensive
understanding of aging in women and possible interventional
options. We also have only a limited understanding of the
relationship between pre-menopausal reproductive status and
endocrinology and post-menopausal sequelae. Nor do we have
much understanding of what determines when menopause
sets in, nor how many oocytes are contained within the
young ovary and their ability to form follicles, both of
which will determine sex hormone output during reproductive
life.
For men, an age-related decline in testosterone production is
associated with reduced cognitive ability, cardiovascular disease,
reduced muscle, and bone strength, besides sexual capacity. Yet
recent research has shown that simply replacing testosterone does
not necessarily ameliorate these symptoms. Firstly, the Leydig
cells of the testes which produce almost all of the testosterone
in the body also generate large amounts of circulating INSL3
as well as 25-OH vitamin D with impacts on bone metabolism
(Ferlin et al., 2013). Secondly, using INSL3 as a robust surrogate
for the testes’ capacity to produce testosterone suggests that this
functional capacity is already established in young men, with
life-long consequences for their ability to produce androgens in
old age. Thus, because the Leydig cells appear neither to divide
nor to regenerate across the adult lifespan, it seems for men
that what they receive after puberty is likely to influence their
capacity to make testosterone in later life. Yet we have very little
understanding of what determines testis growth, development,
and final size across puberty for any species.
Finally, well-being in adult life is very much a reflection of
gonadal function. When this declines in old age, finding an
appropriate replacement will be key to determining whether an
ever extended lifespan will be worthwhile.
EDCs AND THEIR IMPACTS
Environmental EDCs are pervasive substances found in a
wide range of consumer products, cosmetics, urban pollutants,
and biocides. An EDC is defined as “an exogenous substance
or mixture that alters function(s) of the endocrine system
and consequently causes adverse health effects in an intact
organism, or its progeny, or (sub) populations” (WHO/IPCS,
2002). Evidence is accumulating that EDCs may be impacting
negatively on human as well as wildlife populations, and with
consequences particularly for reproductive parameters, though
other physiological systems are also shown to be affected (Gore
et al., 2015). EDC science is controversial, not only because
of the large industrial and political interests involved, but also
because of the nature of the evidence which is weighed. EDCs
are generally present in the environment and in body fluids in
very low concentration. Robust epidemiological studies in large
human populations suggest significant associations between
EDCs and reproductive parameters (e.g., cryptorchidism,
reduced anogenital distance) at concentrations well below levels
considered safe in conventional toxicology studies. The problem
is that animal studies at such low EDC concentrations would
require prohibitively large numbers of animals to have sufficient
power to detect the level of symptom penetrance seen in
human or wildlife populations. Moreover, other than interfering
with endogenous endocrine systems, we still have only a poor
understanding of the molecular mechanisms involved, thus
effectively proscribing the development of suitable in vitro
assays. One reason for this may be that EDCs act by disrupting or
perturbing the kind of signaling networks discussed previously
above, and that impacts may be manifest only as significant
changes to parameter variance rather than to the mean.
Another reason is that EDCs are impacting particularly during
development, for example during fetal organogenesis in the early
second trimester, when a very small impact on a highly dynamic
and differentiating cellular system can have large downstream
effects on cell number, differentiation status, and/or epigenetics.
The subtlety of such impacts is evidenced by the observation
of significant changes to reproductive parameters only in the
subsequent generations from the exposed individuals, pointing
to long-lasting epigenetic changes in the germline. Though
such effects may be small, the socio-economic consequences
can be huge with estimates only for reproductive impacts in the
order of several billion Euros for Europe or the USA every year
(Hauser et al., 2015; Attina et al., 2016). There is a major research
need here to develop sensitive systems which can satisfactorily
predict EDC activity, and which can be applied for regulatory
purposes, though as outlined above, this may require some
considerable paradigm shifts away from conventional testing
strategies.
Although this section has focused on EDCs, much of the
subject area is also relevant for other exogenous interventions,
including nutritional and lifestyle factors, as well as those
inducing oxidative stress.
THE CONSEQUENCES OF ARTIFICIAL
SELECTION
Domestic livestock and companion species have been subjected
to targeted trait selection for many hundreds of years. In many
instances this targeted selection for one characteristic has led
to a concomitant worsening of reproductive parameters. An
obvious example is the relative infertility of high-performance
dairy cattle (Walsh et al., 2011), where evidently high milk yield
is leading to significant negative energy balance at the time of
implantation and gestation, though other factors may also be
involved. Besides shifting to amore weightedmulti-trait breeding
program, what is required here are improved methods of in vitro
oocyte maturation and embryo production, with appropriately
reliable biomarkers, improved determination of estrus, and a
better understanding of the substantial early pregnancy loss. That
∼60% of pregnancy attempts are failing for one reason or another
represents a huge economic burden for the dairy industry. What
is notable is that there appears to be little improvement in
fertility statistics over the last decade, in spite of substantial
research input (Sheldon and Dobson, 2003). In pigs, selection
for high fecundity has also led to increased fetal morbidity and
runting (Vallet et al., 2013), showing that litter size alone is not
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a sufficient parameter, and that we need a better understanding
of the relationship between number of fetuses and their health
outcome.
However, the livestock industry is also undergoing a paradigm
shift, of which we need to take account. In a more ethically
conscious world, increasing hormonal or antibiotic interventions
is no longer desirable. We need to develop alternative routes
(nutritional, behavioral, or via improvedmanagement) to achieve
similar effects.
CONCLUDING REMARKS
Research in reproduction has progressed considerably in recent
decades, particularly in regard to advances in IVF procedures
and reproductive biotechnology. These in turn have opened up
new opportunities not only for human reproduction, but also
for livestock species as well as endangered wildlife. There is
still much potential for further developments in these areas,
particularly in overcoming current technical limitations, for
example, in assisted reproductive techniques for endangered
species, or in regard to male germline transgenesis. The topics
listed above are not intended to be comprehensive, but more to
illustrate the kinds of new thinking in basic research that will be
required to make significant advances in our field. There has also
been little mention here of the major diseases of the reproductive
system, such as polycystic ovarian syndrome, endometriosis, or
cancers of the endometrium, breast, ovary, testis, and prostate.
These are all extremely important areas of research endeavor,
whose understanding will also require similar shifts in our
thinking.
The reproductive system is a very special organ system
which is responsible not only for producing gametes and sex
hormones, but also because it is fundamental to our concept of
individual well-being. Its failures may not be life-threatening, but
its health is key to a robust old-age, to a rich biodiversity, and to
considerable economic advantage.
This new Frontiers section on “Reproduction” aims to
present to its readers new areas of research which represent
an evolution in our thinking about the basic physiology
of reproduction, as well as its translation into clinical,
environmental and livestock practice. We welcome not only
original research articles and reviews, but also hypotheses and
novel concepts, so that our field can be stimulated to grow and
excel.
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